Israel’s Neuromagen is developing a new class of small molecules to treat ALS (Amyotrophic Lateral Sclerosis – Lou Gehrig’s Disease), and other neurodegenerative diseases. The molecules activate the enzyme telomerase reverse transcriptase, which protects and rehabilitates neuronal cells.

https://in.bgu.ac.il/en/pages/news/ALS_neuromagen.aspx

https://www.neuromagen.com/